Palisade Bio Inc reports results for the quarter ended in December - Earnings Summary

Palisade Bio

22/03/2023 22:16

* Palisade Bio Inc  PALI.OQ  reported quarterly adjusted
earnings
of $6.47​​ per share for the quarter ended in December. The mean
expectation of two analysts for the quarter was for a loss of
$2.43 per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Palisade Bio Inc's reported EPS for the quarter was
$6.47​.
    * The mean earnings estimate of analysts had risen by
about 0.6%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Palisade Bio Inc shares had fallen by 65.2% this quarter.
    * The company reported a quarterly loss of $3.72 million.
    * Wall Street's median 12-month price target for Palisade
Bio Inc
is $25.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 22 at 10:15 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -2.43          6.47           Beat
 Sep. 30 2022      -4.00          -4.00          Met
 Jun. 30 2022      -8.50          -6.00          Beat
 Mar. 31 2022      -14.00         -13.00         Beat